⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Reinventing Cancer Immunotherapy just got measured.
4/10 means Reinventing Cancer Immunotherapy is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
Close Main navigation Home About Our team Board of Directors Technology PeptiCHIP News & PR Contact Careers Menu Reinventing Immunotherapy in Oncology and Infectious Disease Contact us ValoTx is developing novel immunotherapies for cancer that are projected to transform treatment and prevention for millions of patients.
Industry: Technology
valotx.com1
Structured Data
2
Content Structure
5
Entity Clarity
4
E-E-A-T Signals
5
Technical AEO
4
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Tech buyers are the most research-intensive shoppers on the internet.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Reinventing Cancer Immunotherapy.
Scored by Engagemii on June 26, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/valotx
Cite this score: Engagemii (2026). "AEO Score for Reinventing Cancer Immunotherapy." Retrieved from https://engagemii.com/aeo/brands/valotx
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform